Clinical Trials of Transfer Factor

S. T. Shulman*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Abstract

To the Editor: Dr. Steele and his co-workers deserve plaudits for their well-designed double-blind trial of dialyzable transfer factor in the prevention of varicella–zoster infections in childhood leukemia (August 14 issue). I wish to point out that the cited leishmania study of Sharma et al. is not the only published double-blind controlled trial to demonstrate the efficacy of transfer factor; our placebo-controlled double-blind trial of this agent in chronic aggressive hepatitis B was published last year.* In addition, I wonder whether Dr. Steele and the rest of us in the fields of infectious disease and immunology should refer to our.

Original languageEnglish (US)
Number of pages1
JournalNew England Journal of Medicine
Volume303
Issue number26
DOIs
StatePublished - Dec 25 1980

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Clinical Trials of Transfer Factor'. Together they form a unique fingerprint.

Cite this